Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • RFK Jr. defends HHS tenure, 12% proposed budget cut
  • Policy / Pricing

RFK Jr. defends HHS tenure, 12% proposed budget cut

BioPharma Dive

Republicans largely praised the HHS secretary s track record during a marathon of House hearings last week, but some raised concerns about proposed budget cuts to the National Institutes of Health.

Policy / PricingRead full story

pharminent April 20, 2026 (Last updated: April 21, 2026)

BioPharma Dive

Republicans largely praised the HHS secretary s track record during a marathon of House hearings last week, but some raised concerns about proposed budget cuts to the National Institutes of Health.

Policy / PricingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout
Next: Trump executive order lifts psychedelics biotechs

Related Stories

  • Policy / Pricing

Decoding Medicare Advantage Coding Intensity

pharminent July 1, 2026
  • Policy / Pricing

UK partners with Eli Lilly on obesity plan

pharminent June 29, 2026
  • Policy / Pricing

EFPIA report adds to pressures on EU drug pricing policy

pharminent June 24, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.